Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | February 14, 2011 |
| Target | Ricerca Biosciences - Efficacy Pharmacology Operating Unit |
| Sector | Life Science |
| Buyer(s) | Numira Biosciences |
| Sellers(s) | Ricerca Biosciences |
| Deal Type | Divestiture |
FILTER BY
| Category | Company |
|---|---|
| Founded | 2005 |
| Sector | Life Science |
Numira Biosciences, Inc. is a rapidly-growing, specialty contract research organization (CRO) that provides powerful imaging solutions for researchers attempting to answer questions related to the onset and progression of disease, drug efficacy, and drug safety in animal models.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Divestiture | 1 of 1 |
| State: Washington | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 2011 | 1 of 1 |
Ricerca Biosciences LLC is a provider of comprehensive, integrated suite of services to accelerate drug development. Company combine nonclinical support for drug candidate selection with analytical and chemical development expertise to bring drug candidates through all phases of development.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Life Science | 1 of 2 |
| Type: Divestiture | 1 of 3 |
| State: Washington | 1 of 1 |
| Country: United States | 1 of 3 |
| Year: 2011 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-09-20 |
Ricerca Biosciences - Pan Labs Pharmacology Unit
United States Pan Labs is a provider in early stage discovery services with a portfolio that provides molecular pharmacology, functional pharmacology, cellular services, and informatics analytics. Pan Labs has built a reputation for maintaining high quality service and customer dependability while delivering the most up-to-date pharmacology assays to match emerging testing needs. |
Sell | - |
